Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.03 (Beat by $0.04) |
EPS GAAP Actual | $0.03 (Beat by $0.04) |
Revenue Actual | $1.53278B |
Revenue Surprise | Beat by $1532.78M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.009908 |
EPS GAAP Estimate | $0.009908 |
Revenue Estimate | $1.994350413B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.06 | 40.5 | 0.05429968 | 0.07964289 | 3 |
Dec 2028 | 0.39 | 6.23 | 0.36929 | 0.41208 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.03 | -0.017412 | 1.53278B | -4.67% | -511.43M |
FQ4 2024 (Dec 2024) | -0.26 | -0.09855 | 1.52249B | 30.64% | 60.95M |
FQ3 2024 (Sep 2024) | -0.29 | -0.29 | 1.45093B | 16.22% | 1450.93M |
FQ4 2019 (Dec 2019) | -0.12 | -0.12 | 0.198126B | 100% | 198.13M |
FQ2 2024 (Jun 2024) | -0.0746 | -0.0746 | 1.48276B | 22.51% | 1482.76M |
FQ1 2024 (Mar 2024) | -0.0148 | -0.0148 | 1.60435B | 29.18% | 1604.35M |
FQ4 2023 (Dec 2023) | -0.45 | -0.45 | 1.05607B | 34.68% | 1056.07M |
FQ3 2023 (Sep 2023) | -0.0776 | -0.0776 | 1.21566B | 42.84% | 1215.66M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.009908
Consensus Revenue Estimates
1.994350413B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.004678 | -- | -0.00480316 | -0.004678 | 1 |
FQ2 2027 (Jun 2027) | 0.027646 | -- | 0.027646 | 0.02838565 | 1 |
FQ1 2027 (Mar 2027) | 0.076805 | -- | 0.076805 | 0.07885986 | 1 |
FQ4 2026 (Dec 2026) | -0.10992 | -- | -0.1158 | -0.10935 | 8 |
FQ3 2026 (Sep 2026) | -0.094518 | -- | -0.09957783 | -0.09402385 | 8 |
FQ2 2026 (Jun 2026) | -0.020995 | -- | -0.02211893 | -0.02088524 | 8 |
FQ1 2026 (Mar 2026) | 0.15316 | 80.41 | 0.15236 | 0.16136 | 8 |
FQ4 2025 (Oct 2025) | -0.04845 | -436.64 | -0.04928729 | -0.04631506 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.87B | -- | 1.87B | 1.91B | 5 |
FQ2 2027 (Jun 2027) | 1.87B | -- | 1.87B | 1.91B | 4 |
FQ1 2027 (Mar 2027) | 1.88B | -- | 1.88B | 1.92B | 8 |
FQ4 2026 (Dec 2026) | 2.3B | -- | 2.29B | 2.39B | 6 |
FQ3 2026 (Sep 2026) | 2.3B | -- | 2.29B | 2.4B | 4 |
FQ2 2026 (Jun 2026) | 2.29B | -- | 2.28B | 2.39B | 4 |
FQ1 2026 (Mar 2026) | 2.31B | 33.62 | 2.3B | 2.4B | 6 |
FQ4 2025 (Oct 2025) | 2.01B | 24.3 | 1.94B | 2.04B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.047412 | 0.03 | -0.017412 | -58.04% |
FQ4 2024 (Dec 2024) | -0.16145 | -0.26 | -0.09855 | 37.9% |
FQ3 2024 (Sep 2024) | -0.29 | -0.29 | 100% | |
FQ4 2019 (Dec 2019) | -0.12 | -0.12 | 100% | |
FQ2 2024 (Jun 2024) | -0.0746 | -0.0746 | 100% | |
FQ1 2024 (Mar 2024) | -0.0148 | -0.0148 | 100% | |
FQ4 2023 (Dec 2023) | -0.45 | -0.45 | 100% | |
FQ3 2023 (Sep 2023) | -0.0776 | -0.0776 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.04B | $1.53B | $-511.43M | -33.37% |
FQ4 2024 (Dec 2024) | $1.46B | $1.52B | $60.95M | 4% |
FQ3 2024 (Sep 2024) | $0B | $1.45B | $1450.93M | 100% |
FQ4 2019 (Dec 2019) | $0B | $0.2B | $198.13M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.48B | $1482.76M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.6B | $1604.35M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.06B | $1056.07M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.22B | $1215.66M | 100% |